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Background
The newly identified HRV-C has been linked to more
severe symptoms of asthma and an increased risk of
prior and subsequent hospital admission. Our research
team has recently reported that despite their sequence
dissimilarity, the HRV-A and HRV-C species have a high
degree of antibody cross-reactivity and the HRV-C speci-
fic antibody response is low (Iwasaki et al., 2013). This
study aims to identify species-specific and cross-reactive
T-cell epitopes for the HRV-A and HRV-C species.
Methods
In total, 110 overlapping synthetic peptides of HRV-A
(genotype HRV-34) and HRV-C (genotype QPM) were
purchased from Mimotopes (Vic, Australia) covering the
entire VP1 protein of both genotypes. T-cell prolifera-
tion was measured by 3H-thymidine incorporation. Per-
ipheral blood mononuclear cells (PBMCs) were isolated
from the blood of 20 adults from the general population
of Perth (WA), with no evidence of current respiratory
illness. The PBMCs were cultured in AIM-V media with
the individual peptides of HRV-A and HRV-C in tripli-
cate. PHA and PPD were included as positive controls
and negative controls contained only media. 3H-thymi-
dine incorporation was measured after a 6-day culture
and a stimulation index of greater than 2 (calculated by
the mean of wells containing antigen divided by the
mean of the negative control wells) was considered a
positive lymphoproliferative response. Variation on
replicate cultures was lower than 20%.
Results
We have identified four species-specific peptides for
HRV-QPM and three for HRV-34 that triggered T-cell
proliferation in more than 50% of the tested subjects.
Four pairs of cross-reactive peptides were identified for
HRV-A and HRV-C that stimulated the cells of more
than 40% of the subjects tested.
Conclusions
To our knowledge, this is the first study to map T-cell epi-
topes in a genotype of HRV-C and also the first to map
the entire HRV VP1 protein. Future HLA typing and in
silico studies for other HRV-A and HRV-C genotypes
based on the reactive peptides will be conducted. These
findings will help to identify differences in the immune
recognition of the two most prevalent HRV species and
are valuable tools for future vaccine development.
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